GlaxoSmithKline fined $491.5M by Chinese court in bribery case

A Chinese court imposed a $491.5 million fine on GlaxoSmithKline, after finding representatives of the pharmaceutical company had bribed Chinese doctors “to obtain improper commercial gains...